At close: 12:26:32 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
8,289.0000
8,289.0000
2,939.0000
4,682.0000
1,798.0000
Cost of Revenue
632.0000
632.0000
1,120.0000
2,776.0000
791.0000
Gross Profit
7,657.0000
7,657.0000
1,819.0000
1,906.0000
1,007.0000
Operating Expense
18,404.0000
18,404.0000
20,055.0000
19,618.0000
23,362.0000
Operating Income
-10,747.0000
-10,747.0000
-18,236.0000
-17,712.0000
-22,355.0000
Net Non Operating Interest Income Expense
1,467.0000
1,467.0000
1,269.0000
217.0000
353.0000
Other Income Expense
559.0000
--
135.0000
263.0000
1,336.0000
Pretax Income
-8,165.0000
-8,165.0000
-15,638.0000
-16,154.0000
-19,732.0000
Net Income Common Stockholders
-8,165.0000
-8,165.0000
-15,638.0000
-16,154.0000
-19,732.0000
Basic EPS
-0.02
--
-0.04
-0.04
-0.05
Diluted EPS
-0.02
--
-0.04
-0.04
-0.05
Basic Average Shares
411,433.0500
--
409,035.2570
406,900.0980
396,875.8570
Diluted Average Shares
411,433.0500
--
409,035.2570
406,900.0980
396,875.8570
Net Income from Continuing & Discontinued Operation
-8,165.0000
-8,165.0000
-15,638.0000
-16,154.0000
-19,732.0000
Normalized Income
-8,165.0000
-8,165.0000
-15,638.0000
-16,154.0000
-19,732.0000
Interest Income
1,467.0000
1,467.0000
1,269.0000
217.0000
353.0000
Net Interest Income
1,467.0000
1,467.0000
1,269.0000
217.0000
353.0000
EBIT
-10,747.0000
-10,747.0000
-18,236.0000
-17,712.0000
-22,355.0000
EBITDA
-9,632.0000
-9,632.0000
-17,042.0000
-16,634.0000
-21,421.0000
Reconciled Cost of Revenue
632.0000
632.0000
1,120.0000
2,776.0000
791.0000
Reconciled Depreciation
1,115.0000
1,115.0000
1,194.0000
1,078.0000
934.0000
Net Income from Continuing Operation Net Minority Interest
-8,165.0000
-8,165.0000
-15,638.0000
-16,154.0000
-19,732.0000
Normalized EBITDA
-9,632.0000
-9,632.0000
-17,042.0000
-16,634.0000
-21,421.0000
6/30/2021 - 9/26/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRP.AX Tissue Repair Ltd
0.2550
-1.92%
RNV.AX RENERVE FPO [RNV]
0.1450
-14.71%
VBS.AX Vectus Biosystems Limited
0.0770
0.00%
RCE.AX Recce Pharmaceuticals Ltd
0.4750
-6.86%
ZLD.AX Zelira Therapeutics Limited
0.6000
0.00%
NOX.AX Noxopharm Limited
0.1000
+1.01%
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%
TYP.AX TRYPTAMINE FPO [TYP]
0.0420
0.00%
PYC.AX PYC Therapeutics Limited
1.5100
-0.66%
RAC.AX Race Oncology Limited
1.3700
-1.44%